NCT07424716 Bone Regeneration Using PRF After Cyst Enucleation
| NCT ID | NCT07424716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sana'a University |
| Condition | Odontogenic Cyst |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-05-19 |
| Primary Completion | 2026-04-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-05-19 with a primary completion date of 2026-04-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled clinical trial aims to evaluate the clinical efficacy of autologous platelet-rich fibrin (PRF) in promoting osseous regeneration following cystic enucleation in the jaws. The study will assess bone healing outcomes and compare PRF application with conventional management methods.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with odontogenic cysts requiring surgical enucleation. * Presence of a postoperative osseous defect in the jaws after cyst enucleation. * Age ≥ 18 years. * Systemically healthy patients (ASA I or II). * Patients willing to participate and sign informed consent. Exclusion Criteria: * Patients with systemic diseases affecting bone healing (e.g., uncontrolled diabetes, osteoporosis). * Patients receiving bisphosphonates or long-term corticosteroid therapy. * Smokers (\>10 cigarettes/day). * Pregnant or lactating women. * Patients with acute infection at the surgical site. * Patients unwilling to participate or unable to attend follow-up visits.
Frequently Asked Questions
Who can join the NCT07424716 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Odontogenic Cyst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07424716 currently recruiting?
Yes, NCT07424716 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sana'a University to inquire about joining.
Where is the NCT07424716 trial being conducted?
This trial is being conducted at Sanaa, Yemen.
Who is sponsoring the NCT07424716 clinical trial?
NCT07424716 is sponsored by Sana'a University. The trial plans to enroll 20 participants.